Morgan Stanley Cuts The Rubicon Project, Inc. (RUBI) to Underweight
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Morgan Stanley downgraded The Rubicon Project, Inc. (NYSE: RUBI) from Equalweight to Underweight with a price target of $8.00 (from $11.00), implying downside of 9%. Analyst Brian Nowak is cautious on growth.
"We are incrementally cautious on RUBI’s forward managed revenue growth trajectory into 2017 and beyond given the growing threat of share losses to smaller ad tech players (such as OpenX and Index Exchange) with more competitive offerings and header bidding functionality," said Nowak. "...we believe AMZN is also presenting a growing threat to RUBI’s ability to gain access to inventory and impressions across the web."
The analyst added, "We also continue to see digital ad dollar gains migrate toward GOOGL and FB and away from smaller players like RUBI given the superior scale and ROI (Exhibit 21). Rubicon has experienced a major slowdown in managed revenue in 2016, with growth expected to slow from 26% in 1Q:16 to just 1% in 4Q:16E (see Exhibit 22). Note that our current below-consensus forecast is baking in a recovery (with growth expected to rebound off of easing compares….but if RUBI is unable to improve its competitive positioning even this may be optimistic."
Shares of The Rubicon Project, Inc. closed at $8.82 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pivotal Research Downgrades Kroger (KR) to Hold
- Jefferies Raises Price Target on US Physical Therapy (USPH) to $63 Following 12-Clinic Acquisition
- JPMorgan Raises Rating on CBOE Holdings (CBOE) to 'Overweight'; Analyst Thinks Bats Technology Will Drive Greater Trading Activity
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS View, Analyst PT Change, Downgrades, Hot Comments
Related EntitiesMorgan Stanley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!